What applications does EVestG™ HAVE? 

Based on peer-reviewed evidence of EVestG™’s potential clinical and research utility, it provides a Diagnostic Decision Support Service to GPs, Specialist Clinicians in respect of:

• Detecting biomarker signature pattern for classifying and stratifying symptom severity for: - 

-   Major Depression (MDD) 

-   The depressive phase of Bipolar Affective Disorder (BPAD)

-   Classifying MDD biomarkers from BPAD biomarkers, 

• Detecting severity of Post Concussive Syndrome (PCS) following mild-Traumatic Brian Injury (mTBI),  

-   Monitoring recovery or relapse, including the emergence of Major Depressive Disorder. 

-   Predicting the potential for the injured person to benefit from repetitive Transcranial Magnetic Stimulation.

• Detecting biomarker signature pattern for classifying and stratifying symptom severity for:

-   Alzheimer’s Disease (AD) 

-   Etiologically Mixed Dementias [predominantly AD and Vascular Dementia] 

• Detecting biomarker signature pattern for classifying and stratifying symptom severity for Parkinson’s Disease (PD) and monitors the influence of Dopamine drug therapy within 90 minutes of dosing

• Provides research technology to neuroscience research institutions.

• Assists Pharmaceutical companies in drug trials.

• Occupational Health and Safety (OH&S): screening employees as to wellness in high stress industries (police; emergency services; mining; aviation; defence forces etc).